#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chorioretinitis Vascular malformation Cardiac sarcoidosis Hepatitis B Neurotrophic keratopathy Angiosarcoma non-metastatic Mixed-type liposarcoma Immune-mediated renal disorder Squamous cell carcinoma of the hypopharynx Chronic myeloid leukaemia (in remission) Waldenstrom's macroglobulinaemia Proteus syndrome Neurofibromatosis Pouchitis Cognitive disorder More trials…

    Learn about Rare Diseases

    X-linked lymphoproliferative syndrome – Life with Disease Leiomyosarcoma recurrent – Diagnostics Pelizaeus-Merzbacher disease – Basic Information Myelodysplastic syndrome with excess blasts Idiopathic pulmonary fibrosis – Life with Disease Lennox-Gastaut syndrome Pemphigoid – Basic Information Hairy cell leukaemia – Life with Disease Hypereosinophilic syndrome – Diagnostics Acquired haemophilia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iclepertin Ebastine Ammonium Chloride Bp Benzyl Alcohol Sodium Hypochlorite Glasdegib SIGVOTATUG VEDOTIN Avatrombopag Folic Acid ORG-129 Anhydrous Benzoyl Peroxide A52 HALOBETASOL PROPIONATE Enfuvirtide [18F]Fluoro-Peg-Folate Ifinatamab Deruxtecan Pegargiminase Mometasone Furoate Monohydrate Thiamine Amniotic Membrane, Human More therapies…

    Learn about Your Condition

    PIK3CA-activated mutation Osteoporosis postmenopausal Malignant melanoma stage IV BRAF gene mutation Hyperchylomicronaemia Nephropathy Pancreatitis chronic Cutaneous lupus erythematosus Wiskott-Aldrich syndrome Alport's syndrome Obstructive pancreatitis Neurodegenerative disorder Cardiac disorder Primary hypercholesterolaemia Laparoscopic surgery More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Slaskie Centrum Chorob Serca W Zabrzu

Slaskie Centrum Chorob Serca W Zabrzu

Ul. Marii Curie-Sklodowskiej 9, Zabrze, 41-800, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Effect of Ferric Carboxymaltose, Ferrous Sulfate, and Sodium Chloride vs Placebo on Physical Performance in Frail Elderly with Iron Deficiency and Cardiovascular Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Iron deficiency
    Investigated Drugs:
    • Dried Ferrous Sulfate
    • Ferric Carboxymaltose
    • Sodium Chloride
    Poland

  • Study comparing high-dose and low-dose aspirin with prasugrel and aspirin combination in patients after coronary artery bypass grafting surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic coronary syndrome
    • Coronary artery disease
    Investigated Drugs:
    • Prasugrel
    • Acetylsalicylic Acid
    Poland

  • Study of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation

    Recruiting

    2 1
    Investigated Drugs:
    • AP31969 SULFATE
    Bulgaria Denmark Germany Hungary Italy The Netherlands +1

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6

  • Study on the Effects of CDR132L on Heart Structure and Function in Patients with Heart Failure and Left Ventricular Hypertrophy

    Recruiting

    2 1
    Investigated Diseases:
    • Cardiac failure
    Germany Poland Spain

  • Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Czechia Denmark France Germany Greece +8

  • Study on the Effects of Sacubitril/Valsartan and Ramipril on Heart Function in Patients with Ischemic Heart Failure with Mid-Range Ejection Fraction

    Recruiting

    3 1 1
    Investigated Drugs:
    • Sacubitril
    • Hydrochlorothiazide
    • Ramipril
    Poland

  • Study on Sacubitril and Valsartan to Prevent Heart Damage in Breast Cancer Patients Undergoing Treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Poland

  • Study on Valsartan and Sacubitril for Preventing Disease Progression in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Poland

  • Study on the Effects of Ferric Carboxymaltose on Heart Health and Quality of Life in Patients with Recent Heart Attack and Iron Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Myocardial infarction
    Investigated Drugs:
    • Ferric Carboxymaltose
    • Sodium Chloride
    Poland
1 2 3
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!